Skip to main content
Heart logoLink to Heart
. 1998 Oct;80(4):365–369. doi: 10.1136/hrt.80.4.365

Nitrate induced coronary vasodilatation: differential effects of sublingual application by capsule or spray

M Pfister 1, C Seiler 1, M Fleisch 1, H Gobel 1, T Luscher 1, B Meier 1
PMCID: PMC1728824  PMID: 9875113

Abstract

Background—Sublingual nitroglycerin (glyceryltrinitrate, GTN) capsules or isosorbide dinitrate (ISDN) spray are routinely used to treat anginal attacks and to vasodilate maximally the epicardial coronary arteries during coronary angiography.
Objective—To compare the coronary vasodilatory effects of GTN capsules and ISDN spray with those induced by intracoronary GTN using quantitative coronary angiography.
Design—96 patients (79 men and 17 women; median age 59 years) were randomised to four groups to receive either a sublingual capsule containing 0.8 mg GTN or two puffs of spray delivering 0.8 mg ISDN, followed or preceded by an intracoronary bolus of 0.2 mg GTN used as reference for maximal vasodilatation.
Results—There was a significant increase in the mean diameter of coronary arteries in angiographically normal segments in patients who received either intracoronary GTN (groups 1 and 2) or ISDN spray (group 4) as a first application (group 1, 0.46 mm, +17%, (baseline vessel diameter 100%), p < 0.001; group 2, 0.45 mm, +13%, p < 0.001; group 4, 0.47 mm, +13%, p < 0.05). Patients who received a sublingual GTN capsule as the first application mode (group 3) had no significant change in epicardial vessel diameter (0.10 mm, +5%, p = 0.3).
Conclusions—Sublingual ISDN spray may be more efficacious than sublingual GTN capsules in certain patients with anginal attacks. ISDN spray should be preferred over capsules in coronary angiographic procedures.

 Keywords: angiography;  isosorbide dinitrate;  nitroglycerin;  vasodilatation;  angina

Full Text

The Full Text of this article is available as a PDF (117.9 KB).

Figure 1  .

Figure 1  

Changes in vessel diameter (% change of baseline vessel diameter) of angiographically normal proximal coronary artery segments after application of different nitrate formulations. NTG ic, intracoronary bolus of 0.2 mg glyceryltrinitrate; ISDN, two puffs of a spray delivering 0.4 mg isosorbide dinitrate; GTN caps, glyceryltrinitrate capsules.

Figure 2  .

Figure 2  

Changes in pulmonary capillary wedge pressure (% change of baseline pressure) during right heart catheterisation after different modes of nitrate administration. NTG ic, intracoronary bolus of 0.2 mg glyceryltrinitrate; ISDN, two puffs of a spray delivering 0.4 mg isosorbide dinitrate; GTN caps, glyceryltrinitrate capsules.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. The role of nitrates in coronary heart disease. Arch Intern Med. 1995 Feb 27;155(4):357–364. [PubMed] [Google Scholar]
  2. Culling W., Singh H., Bashir A., Griffiths B. E., Dalal J. J., Sheridan D. J. Haemodynamics and plasma concentrations following sublingual GTN and intravenous, or inhaled, isosorbide dinitrate. Br J Clin Pharmacol. 1984 Feb;17(2):125–131. doi: 10.1111/j.1365-2125.1984.tb02326.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Feldman R. L., Marx J. D., Pepine C. J., Conti C. R. Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation. 1982 Aug;66(2):321–327. doi: 10.1161/01.cir.66.2.321. [DOI] [PubMed] [Google Scholar]
  4. Fung H. L. Do nitrates differ? Br J Clin Pharmacol. 1992;34 (Suppl 1):5S–9S. doi: 10.1111/j.1365-2125.1992.tb04141.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goldstein R. E., Rosing D. R., Redwood D. R., Beiser G. D., Epstein S. E. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation. 1971 May;43(5):629–640. doi: 10.1161/01.cir.43.5.629. [DOI] [PubMed] [Google Scholar]
  6. Lüscher T. F. Endogenous and exogenous nitrates and their role in myocardial ischaemia. Br J Clin Pharmacol. 1992;34 (Suppl 1):29S–35S. doi: 10.1111/j.1365-2125.1992.tb04146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986 Jul;78(1):1–5. doi: 10.1172/JCI112536. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES